River Stone Biotech ISG ApS: Financial statements 2022
CVR: 42596787
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
River Stone Biotech ISG ApS (CVR 42596787) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,153,513 and a net result of DKK -2,398,558. Equity in the 2022 report amounted to DKK 864,016. The solvency ratio was 10.7%.
- Gross Profit
- DKK 5,153,513
- Profit/Loss
- DKK -2,398,558
- Equity
- DKK 864,016
- Total Assets
- DKK 8,073,936
Official annual report
Keep an eye on River Stone Biotech ISG ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
River Stone Biotech ISG ApS has published its interim report for the period August 10, 2021 to December 31, 2021.
About River Stone Biotech ISG ApS
River Stone Biotech ISG ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2021. The company has been dissolved on 20 June 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK 1,625,265 and a net result of DKK -1,109,600 compared with DKK -2,398,558 the year before. Equity in the 2023 report amounted to DKK -245,584.